Susquehanna International Group, LLP Voyager Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.77 - $9.27 $31,157 - $50,058	5,400 Added 26.47%	25,800 $150,000
Q2 2024 Aug 15, 2024	SELL	$7.42 - $10.54 $122,430 - $173,910	-16,500 Reduced 44.72%	20,400 $161,000
Q1 2024 May 07, 2024	BUY	$7.15 - $10.84 $140,140 - $212,464	19,600 Added 113.29%	36,900 $343,000
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $256,224 - $359,448	-40,800 Reduced 70.22%	17,300 $146,000
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $234,805 - $349,875	31,100 Added 115.19%	58,100 $450,000
Q2 2023 Aug 11, 2023	SELL	$6.94 - $13.99 $909,140 - $1.83 Million	-131,000 Reduced 82.91%	27,000 $309,000
Q1 2023 May 16, 2023	BUY	$6.0 - $10.78 $948,000 - $1.7 Million	158,000 New	158,000 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $86,335 - $115,785	-15,500 Reduced 21.89%	55,300 $327,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $207M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.